Balaji Amines (NSE:BALAMINES) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BALAMINES Balaji Amines Ltd NSE:BALAMINES
78 GF Score
Price ₹2,289.10
GF Value ₹1,665.83
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Balaji Amines Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Balaji Amines is: Low Risk: Strong fundamentals, worth long-term holding.

Balaji Amines  (NSE:BALAMINES) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Balaji Amines Risk Assessment Related Terms

NSE:BALAMINES vs LIN, SHW, ECL: Risk Assessment Comparison

For the Specialty Chemicals subindustry, Balaji Amines's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Balaji Amines Risk Assessment vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Balaji Amines's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Balaji Amines's Risk Assessment falls into.


NSE:BALAMINES
78GF Score
Balaji Amines Ltd NSE:BALAMINES
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?

Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued. The current stock price of ₹2,289.10 is trading 37.4% above its estimated GF Value™ of ₹1,665.83. GuruFocus considers Balaji Amines to be Significantly Overvalued.

Key valuation signals for NSE:BALAMINES:

  • Risk Assessment:
  • GF Value™: ₹1,665.83 vs. price of ₹2,289.10 (37.4% above fair value)
  • GF Score™: 78/100 with 9 warning signs

No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Balaji Amines Business Description

Other Exchanges 530999:India
Address Plot No. 47, Kavuri Hills, Balaji Bhawan, Behind Jubilee Ridge Hotel, Madhapur, Hyderabad, TG, IND, 500 003
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
78GF Score

Get the complete analysis for NSE:BALAMINES

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,289.10
Price
₹1,665.83
GF Value